📊 Score Breakdown
Offering Ability
60
Cash Runway
95
Float Risk
27
Warrant Exposure
30
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
61%
🔄 Reverse Split
70%
• 50-day avg $0.79 below $1 exchange minimum
• Only 0 months cash — financial pressure
💰 Capital Raise
55%
• Critical: only 0.5 months cash remaining
📉 Score Deterioration
50%
• Score rose 48 points recently (worsening)
• Score in HIGH risk zone (69/100)
💹 Market Data
Market Cap$29.65M
Shares Outstanding36.10M
Float24.95M
Cash$166.0K
Debt$170.0K
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 2.4% shares (2025Q4 vs prior)
13 institutional holders · 346.1K shares
#1
Yorkville Advisors Global, LP
100.0K shares
#2
TWO SIGMA INVESTMENTS, LP
51.5K shares
#3
MEITAV INVESTMENT HOUSE LTD
40.0K shares
+ 10 more holders Sign up free to view →
📉 Short Interest
Short Interest487.3K
Days to Cover3.6
% of Float1.9%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2025
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for NRSN
📊 NRSN FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 NRSN Signal Convergence & Dark Pool Activity — StonkWhisper
📄 NRSN Dilution Risk Analysis — Full In-Depth Report
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.